Ketamine's efficacy in chronic soreness as an antidepressant far outlast the particular drug concentrations and is particularly potentially mediated by a secondary boost in structural synaptic connectivity mediated by a neuronal reaction to the ketamine-induced "hyper-glutamatergic condition." The N-methyl-D-aspartate (NMDA) receptor has a signific